Article ID Journal Published Year Pages File Type
333365 Psychiatry Research 2015 45 Pages PDF
Abstract

•Primary psychopathy can be situated on a continuum spanning from controlled to disinhibited.•Serotonergic hyperstability mediates the emotional deficiency in primary psychopathy.•Primary psychopathy is generally related to higher tonic/population activity of mesolimbic DA.•However, pathologically heightened mesolimbic DA increases the risk for disinhibited subtypes.•In addition, mesocortical DA hypofunctionality further increases risk for disinhibited subtypes.

Despite similar emotional deficiencies, primary psychopathic individuals can be situated on a continuum that spans from controlled to disinhibited. The constructs on which primary psychopaths are found to diverge, such as self-control, cognitive flexibility, and executive functioning, are crucially regulated by dopamine (DA). As such, the goal of this review is to examine which specific alterations in the meso-cortico-limbic DA system and corresponding genes (e.g., TH, DAT, COMT, DRD2, DRD4) might bias development towards a more controlled or disinhibited expression of primary psychopathy. Based on empirical data, it is argued that primary psychopathy is generally related to a higher tonic and population activity of striatal DA neurons and lower levels of D2-type DA receptors in meso-cortico-limbic projections, which may boost motivational drive towards incentive-laden goals, dampen punishment sensitivity, and increase future reward-expectancy. However, increasingly higher levels of DA activity in the striatum (moderate versus pathological elevations), lower levels of DA functionality in the prefrontal cortex, and higher D1-to-D2-type receptor ratios in meso-cortico-limbic projections may lead to increasingly disinhibited and impetuous phenotypes of primary psychopathy. Finally, in order to provide a more coherent view on etiological mechanisms, we discuss interactions between DA and serotonin that are relevant for primary psychopathy.

Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, ,